E3 Ubiquitin-Protein Ligase CBL-C (CBLC) anticorps
Aperçu rapide pour E3 Ubiquitin-Protein Ligase CBL-C (CBLC) anticorps (ABIN7468288)
Antigène
Reactivité
Hôte
Clonalité
Conjugué
Application
-
-
Réactivité croisée
- Souris
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogène
- Recombinant protein encompassing a sequence within the center region of human CBLC. The exact sequence is proprietary.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB: 1:500-1:3000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
-
Commentaires
-
Positive Control: mouse kidney
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.8 mg/mL
-
Buffer
- 0.1M Tris-Glycine ( pH 7), 20 % Glycerol, 0.01 % Thimerosal
-
Agent conservateur
- Thimerosal (Merthiolate)
-
Précaution d'utilisation
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- E3 Ubiquitin-Protein Ligase CBL-C (CBLC)
-
Autre désignation
- Cbl proto-oncogene C
-
Sujet
-
Synonyms: Cbl proto-oncogene C , CBL-3 , CBL-SL , RNF57
Background: CBL proteins, such as CBLC, are phosphorylated upon activation of a variety of receptors that signal via protein tyrosine kinases. Through interactions with proteins containing SRC (MIM 190090) homology-2 (SH2) and SH3 domains, CBL proteins modulate downstream cell signaling (Keane et al., 1999 [PubMed 10362357]).[supplied by OMIM]
-
Poids moléculaire
- 52 kDa
-
ID gène
- 23624
-
UniProt
- Q9ULV8
Antigène
-